Moderna
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
MRNA Key Statistics
MRNA News
Shares of Moderna MRNA rose 3% on Wednesday after management announced positive clinical updates at its Vaccines Day Event, highlighting its pipeline progress....
Moderna MRNA announced positive results from the pivotal phase III NextCOVE study evaluating mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine...
Moderna (MRNA) is advancing three of its vaccines into Phase Three trials as the pharmaceutical giant hopes to expand its product pipeline past its COVID-19 vac...
Analyst ratings
50%
of 26 ratingsMore MRNA News
Moderna (NASDAQ:MRNA) gave some key updates regarding its pipeline ahead of its Vaccine Day event and made it clear that the biotech company has more to offer b...
Loading... Loading... Moderna Inc MRNA shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3...
Blackstone (BX) announced a new collaboration with Moderna (MRNA) through a development and commercialization funding agreement where funds managed by Blackston...
Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technology NEW YORK, March 27, 2024--(BUSINESS WIRE)--Blackstone (NYSE:BX) ann...
Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts...
Loading... Loading... On Tuesday, Cathie Wood’s Ark Invest made a significant move by increasing its stake in Moderna Inc. MRNA, a leading COVID-19 vaccine mak...
Loading... Loading... Tuesday, Moderna Inc MRNA said that mRNA-1283, the company’s next-generation COVID-19 vaccine, has met the primary endpoints of its Phase...